Liu, L., Liu, Y., Liu, J., Yu, X., Li, S., Wang, J., Zhang, Y., Guo, S., Zhang, J., Li, Y., Xie, Y., Zhou, L., Zhao, Y. (2025). First-line envafolimab in combination with recombinant human endostatin and chemotherapy for advanced squamous non-small cell lung cancer: Updated results from a prospective, single-arm, multicenter phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8573